Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-000764
Filing Date
2018-01-08
Accepted
2018-01-08 21:30:25
Documents
1
Period of Report
2018-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4093
  Complete submission text file 0000899243-18-000764.txt   5488
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Brown Bob D (Reporting) CIK: 0001598479 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 18517719